Evidence map›Paper›PMID 39419553›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

Improved Localization of Insulinomas Using

Marti Boss, Olof Eriksson, Kirsi Mikkola, Annemarie Eek, Maarten Brom, Mijke Buitinga, Adrienne H Brouwers, Irina Velikyan, Beatrice Waser, Saila Kauhanen and 13 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Radiosynthesis and preclinical evaluation of [EJNMMI radiopharmacy and chemistry · 2026
    Article
  5. Article
  6. Development of an automated radiosynthesis for [EJNMMI radiopharmacy and chemistry · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Glucagon-like peptide-1 receptor PET/CT withEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Marti BossDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands; marti.boss@radboudumc.nl.
Olof ErikssonDepartment of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Kirsi MikkolaTurku PET Center, University of Turku, Turku, Finland.
Annemarie EekDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Maarten BromDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Mijke BuitingaDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Adrienne H BrouwersDepartment of Nuclear Medicine, University Medical Center Groningen, Groningen, The Netherlands.
Irina VelikyanDepartment of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Beatrice WaserPathology Länggasse, Bern, Switzerland.
Saila KauhanenTurku PET Center, University of Turku, Turku, Finland.
Olof SolinTurku PET Center, University of Turku, Turku, Finland.
Camille MarciniakDepartment of General and Endocrine Surgery, University Hospital Lille, Lille, France.
Barbro ErikssonSection for Endocrine Oncology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Jean-Claude ReubiInstitute of Pathology, Cell Biology and Experimental Cancer Research, University of Bern, Bern, Switzerland.
Cyrielle AvelineDepartment of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France.
Damian WildDivision of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
Francois PattouDepartment of General and Endocrine Surgery, University Hospital Lille, Lille, France.
Jean-Noel TalbotDepartment of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France.
Johannes HoflandSection of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Anders SundinDepartment of Surgical Sciences, Radiology and Molecular Imaging, Uppsala University, Uppsala, Sweden; and.
Pirjo NuutilaTurku PET Center, University of Turku, Turku, Finland.
John HermansDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Martin GotthardtDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise anatomic localization of insulinomas is crucial for surgical treatment. Current routine noninvasive imaging techniques, including CT, MRI, and

Indexed as

ExenatideGallium RadioisotopesHeterocyclic Compounds, 1-RingInsulinomaPositron Emission Tomography Computed TomographyAcetatesAdultAgedFemaleHumansMaleMiddle AgedPancreatic NeoplasmsPeptidesProspective StudiesRadiopharmaceuticals1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononaneAcetatesExenatideGallium RadioisotopesHeterocyclic Compounds, 1-RingPeptidesRadiopharmaceuticalsVenomsdiagnostic imagingexendin PET/CTGLP-1 receptorinsulinoma

Identifiers

PMID39419553
PMCPMC11619583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.